I like:
- Increase of 121% on the March quarter 2019.
- Financial year-end Cash Receipts to June 2019 of $32,221,000 wereup 36% compared to the prior financial year (to June 2018).- This indicates that more EPP patients in Europe arereceiving treatment with SCENESSE® and we look forward to the time the same treatment access can be provided toAmerican EPP patients who have no current alternatives.”
- Net Cash from Operations was positive by $8,618,000 in the June quarter 2019. Net Cash from Operations for thetwelve months to 30 June 2019 was a positive $18,382,000 compared to a positive $11,693,000 in the same twelvemonth period to 30 June 2018.
- Increasing cash balance - Cash Balance as at 30 June2019 increased to $54,269,000, compared to $44,975,000 as at 31 March 2019 and $36,198,000 as at 30 June 2018.
Very positive outlook and building blocks foundation.
Well done!
- Forums
- ASX - By Stock
- CUV
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-4
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.57 |
Change
0.170(1.10%) |
Mkt cap ! $780.1M |
Open | High | Low | Value | Volume |
$15.38 | $15.63 | $15.25 | $751.5K | 48.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 165 | $15.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.59 | 106 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 165 | 15.530 |
1 | 165 | 15.510 |
1 | 165 | 15.490 |
1 | 165 | 15.460 |
1 | 35 | 15.400 |
Price($) | Vol. | No. |
---|---|---|
15.590 | 106 | 1 |
15.600 | 187 | 1 |
15.630 | 3009 | 2 |
15.650 | 1010 | 1 |
15.660 | 165 | 1 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$15.57 |
  |
Change
0.170 ( 0.95 %) |
|||
Open | High | Low | Volume | ||
$15.39 | $15.63 | $15.33 | 8111 | ||
Last updated 15.59pm 24/05/2024 ? |
Featured News
CUV (ASX) Chart |